NAVBQ (Navidea Biopharmaceuticals) Days Payable: 0.00 (As of Sep. 2023)

What is Navidea Biopharmaceuticals Days Payable?

Navidea Biopharmaceuticals NAVBQ 16 Days Payable is 0.00 as of Sep. 2023. GuruFocus rates NAVBQ with a GF Score™ of 16/100.

Navidea Biopharmaceuticals's average Accounts Payable for the three months ended in Sep. 2023 was $2.04 Mil. Navidea Biopharmaceuticals's Cost of Goods Sold for the three months ended in Sep. 2023 was $0.00 Mil.

The historical rank and industry rank for Navidea Biopharmaceuticals's Days Payable or its related term are showing as below:

NAVBQ's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.56
* Ranked among companies with meaningful Days Payable only.

Navidea Biopharmaceuticals's Days Payable declined from Sep. 2022 (1,407.95) to Sep. 2023 (0.00). It may suggest that Navidea Biopharmaceuticals accelerated paying its suppliers.

Navidea Biopharmaceuticals Days Payable Related Terms

Navidea Biopharmaceuticals Days Payable Historical Data

* Premium members only.

The historical data trend for Navidea Biopharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Navidea Biopharmaceuticals Days Payable Chart

Navidea Biopharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

2,408.25

40,071.79

415,005.00

0.00

3,496.11

Navidea Biopharmaceuticals Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Payable	Get a 7-Day Free Trial															1,407.95	3,524.08	0.00	0.00	0.00

NAVBQ vs PKBO, RSPI, ATRX: Days Payable Comparison

For the Biotechnology subindustry, Navidea Biopharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Navidea Biopharmaceuticals Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Navidea Biopharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Navidea Biopharmaceuticals's Days Payable falls into.

Save Embed

16GF Score

Navidea Biopharmaceuticals Inc NAVBQ

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Navidea Biopharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Navidea Biopharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (1.421	+	2.123)	/	2 )	/	0.185	*	365
=	1.772					/	0.185	*	365
=	3,496.11

Navidea Biopharmaceuticals's Days Payable for the quarter that ended in Sep. 2023 is calculated as:

	Days Payable (Q: Sep. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Sep. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2023 )	*	Days in Period
=	( (2.008	+	2.071)	/	2 )	/	0	*	365 / 4
=	2.0395					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

Navidea Biopharmaceuticals (NAVBQ) has a Days Payable of 0.00 as of Sep. 2023. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Navidea Biopharmaceuticals and its competitors.

Is Navidea Biopharmaceuticals' Days Payable too high?

Navidea Biopharmaceuticals' current Days Payable is 0.00. Overall, Navidea Biopharmaceuticals has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.

How does Navidea Biopharmaceuticals' Days Payable compare to PKBO and RSPI?

Navidea Biopharmaceuticals' Days Payable of 0.00 can be compared against companies in the Biotechnology industry. The industry median Days Payable is 113.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.56, based on 706 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Navidea Biopharmaceuticals and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Navidea Biopharmaceuticals's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Navidea Biopharmaceuticals stock overvalued right now?

Navidea Biopharmaceuticals (NAVBQ) has a current Days Payable of 0.00. The current Days Payable is 0.00. Navidea Biopharmaceuticals' overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For Navidea Biopharmaceuticals (NAVBQ), the current Days Payable is 0.00 as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Navidea Biopharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies PKBO RSPI ATRX ARDS NYMXF CNBX IVRN ATHXQ EMMA BTTX OCSE:NOVO B REGN VRTX ASX:CSL XKRX:207940 ALNY XBRU:UCB XKRX:068270 MRNA XBRU:ARGX

Address 4995 Bradenton Avenue, Suite 240, Dublin, OH, USA, 43017-3552

Website https://www.navidea.com

Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its products, precision immunodiagnostic agents and immunotherapeutic products are designed to assist in the identification of undetected diseases and to improve targeted treatment. The company's platform, known as Manocept technology, aims to develop next-generation targeted diagnostics and therapies for cancer, autoimmune conditions, and other inflammatory diseases. One of the company's products is Lymphoseek, a radioactive diagnostic agent indicated to locate lymph nodes.

16GF Score

Get the complete analysis for NAVBQ

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View NAVBQ Analysis

See Days Payable data for all stocks →